Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor

Clinical Immunology

Volumn 127, Issue 1, 2008, Pages 7-13

  Arima, Takayasu ^a   Shimojo, Naoki ^a   Yamaguchi, Ken ichi ^a   Tomiita, Minako ^a   Kohn, Leonard D ^b   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b OHIO UNIVERSITY   (United States)

Author keywords

Graves' disease; Intranasal tolerance; Mouse model; T cell epitope; Thyrotropin receptor

Indexed keywords

AMINO ACID; CARBOXYALANYLLEUCYLLYSYLGLUTAMYLLEUCYLPROLYLLEUCYLLEUCYLLYSYL PHENYLALANYLLEUCYLGLYCYLISOLEUCYLPHENYLALANYLASPARAGINYLTHREONYL GLYCYLLEUCYLLYSYLMETHIONINAMIDE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PEPTIDE; PEPTIDE DERIVATIVE; THYROTROPIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; GRAVES DISEASE; HYPERTHYROIDISM; IMMUNIZATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MORBIDITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ADMINISTRATION, INTRANASAL; ANIMALS; CELL PROLIFERATION; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FEMALE; FIBROBLASTS; GRAVES DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOTHERAPY; MICE; PEPTIDES; RECEPTORS, THYROTROPIN; T-LYMPHOCYTES; TRANSFECTION;

EID: 40849116141     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.11.007     Document Type: Article

References (24)

1. Shimojo N., Kohno Y., Yamaguchi K., et al. Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 11074-11079
2. Bottazzo G.F., Pujol-Borrell R., Hanafusa T., and Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 8359 (1983) 1115-1119
3. Sospedra M., Obiols G., Babi L.F., Tolosa E., Vargas F., Roura-Mir C., Lucas-Martin A., Ercilla G., and Pujol-Borrell R. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?. J. Immunol. 154 (1995) 4213-4222
4. Mullins R.J., Cohen S.B., Webb L.M., Chernajovsky Y., Dayan C.M., Londei M., and Feldmann M. Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines. J. Clin. Invest. 96 (1995) 30-37
5. Wu H.Y., Ward F.J., and Staines N.A. Histone peptide-induced nasal tolerance: suppression of murine lupus. J. Immunol. 169 (2002) 1126-1134
6. Staines N.A., Harper N., Ward F.J., Malmstrom V., Holmdahl R., and Bansal S. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Clin. Exp. Immunol. 103 (1996) 368-375
7. Tian J., Atkinson M.A., Clare-Salzler M., Herschenfeld A., Forsthuber T., Lehmann P.V., and Kaufman D.L. Nasal administration of glutamate decarboxylase (GAD 65) peptides induced Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183 (1996) 1561-1567
8. Metzler B., and Wraith D.C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 5 (1993) 1159-1165
9. Baggi F., Andreetta F., Caspani E., Milani M., Longhi R., Mantegazza R., Cornelio F., and Antozzi C. Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis. J. Clin. Invest. 104 (1999) 1287-1295
10. Yamaguchi K., Shimojo N., Kikuoka S., Hoshioka A., Hirai A., Tahara K., Kohn L.D., Kohno Y., and Niimi H. Genetic control of anti-thyrotropin receptor antibody generation in H-2K mice immunized with thyrotropin receptor-transfected fibroblasts. J. Clin. Endocrinol. Metab. 82 (1997) 4266-4269
11. Fremont D.H., Monnaie D., Nelson C.A., Hendrickson W.A., and Unanue E.R. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 8 (1998) 305-317
12. Nelson C.A., Viner N.J., Young S.P., Petzold S.J., and Unanue E.R. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak. J. Immunol. 157 (1996) 755-762
13. Chicz R.M., Urban R.G., Gorga J.C., Vignali D.A., Lane W.S., and Strominger J.L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178 (1993) 27-47
14. Reid P.A., and Watts C. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature 346 (1990) 655-657
15. Jin Y., Shih W.K., and Berkower I. Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen. J. Exp. Med. 168 (1988) 293-306
16. Mullins R.J., Chernajovsky Y., Dayan C., Londei M., and Feldman M. Transfection of thyroid autoantigens into EBV-transformed B cell lines. Recognition by Graves' disease thyroid T cells. J. Immunol. 152 (1994) 5572-5580
17. Weiss S., and Bogen B. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 282-286
18. Yurin V.L., Rudensky A.Y., Mazel S.M., and Blechman J.M. Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule. Eur. J. Immunol. 19 (1989) 1685-1691
19. Malnati M.S., Marti M., LaVaute T., Jaraquemada D., Biddison W., DeMars R., and Long E.O. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells. Nature 357 (1992) 702-704
20. Staines N.A., Derry C.J., Marinova-Mutafchieva L., Ali N., Davies D.H., and Murphy J.J. Constraints on the efficacy of mucosal tolerance in treatment of human and animal arthritic diseases. Ann. N.Y. Acad. Sci. 1029 (2004) 250-259
21. Hufnagl K., Winkler B., Focke M., Valenta R., Scheiner O., Renz H., and Wiedermann U. Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice. J. Allergy Clin. Immunol. 116 (2005) 370-376
22. Guimaraes V.C., Quintans J., Fisfalen M.-E., Straus F.H., Wilhelm K., Madeiros-Neto G.A., and DeGroot L.J. Suppression of development of experimental autoimmune thyroiditis by oral administration of thyroglobulin. Endocrinology 136 (1995) s 3353-s 3359
23. Peterson K.E., and Braley-Mullen H. Suppression of murine experimental autoimmune thyroiditis by oral administration of porcine thyroglobulin. Cell. Immunol. 166 (1995) 123-130
24. Kita M., Ahmad L., Marians R.C., Vlase H., Unger P., Graves P.N., and Davies T.F. Regulation and transfer of a murine model of thyrotropin receptor antibody mediated Graves' disease. Endocrinology 140 (1999) 1392-1398